Ritholtz Wealth Management’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.9M | Buy |
36,284
+1,225
| +3% | +$132K | 0.09% | 146 |
|
|
2025
Q1 | $3.54M | Buy |
35,059
+2,413
| +7% | +$243K | 0.11% | 132 |
|
|
2024
Q4 | $2.92M | Buy |
32,646
+4,050
| +14% | +$362K | 0.09% | 150 |
|
|
2024
Q3 | $2.4M | Buy |
28,596
+5,303
| +23% | +$444K | 0.07% | 191 |
|
|
2024
Q2 | $1.79M | Buy |
23,293
+3,643
| +19% | +$281K | 0.06% | 223 |
|
|
2024
Q1 | $1.35M | Sell |
19,650
-2,205
| -10% | -$151K | 0.05% | 286 |
|
|
2023
Q4 | $1.26M | Buy |
21,855
+1,208
| +6% | +$69.8K | 0.05% | 258 |
|
|
2023
Q3 | $1.09M | Buy |
20,647
+1,440
| +7% | +$76K | 0.05% | 252 |
|
|
2023
Q2 | $1.04M | Buy |
19,207
+2,153
| +13% | +$116K | 0.05% | 263 |
|
|
2023
Q1 | $853K | Buy |
17,054
+11,538
| +209% | +$577K | 0.04% | 298 |
|
|
2022
Q4 | $255K | Sell |
5,516
-13,279
| -71% | -$614K | 0.01% | 486 |
|
|
2022
Q3 | $728K | Buy |
+18,795
| New | +$728K | 0.04% | 312 |
|